Pharmacyclics, Inc. (NSDQ: PCYC), a Sunnyvale, CA biopharma with four drugs in clinical development, may be developing a business model that involves China. However, at this stage, the evidence for such a move is sketchy, at best. The following is what we know, and you can decide for yourself whether the company's business plan will soon include a China component. More details...